Alamar and Nightingale Study Maps Early Blood Protein Signals of Neurodegeneration
Researchers used Alamar's NULISA platform to measure hundreds of blood proteins across 80,000 UK Biobank participants. The study aims to identify molecular markers of neurodegeneration that could enable diagnosis before symptoms appear. Such earlier detection could open windows for intervention that are not currently available. The article argues that identifying a protein on a data plot is only a first step, since understanding its structure and mechanism requires further analysis. It introduces NexoPeek, a Meta Quest application that lets users explore protein structures at human scale in virtual reality.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)
Log in to join the discussion and vote.
Log in